Intellia Therapeutics, Inc. (NTLA)

9.71 +0.48 (+5.20%) USD  |  NASDAQ  |  Dec 22, 13:10
More

Intellia Therapeutics EPS Diluted from Continuing Operations (Quarterly)

EPS Diluted from Continuing Operations (Quarterly) Chart

View EPS Diluted from Continuing Operations (Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Continuing Operations (Quarterly) Benchmarks

View EPS Diluted from Continuing Operations (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Pacific Biosciences of California, Inc. Upgrade